The Pharma Letter3h
China “Breakthrough” status for Hutchmed’s Orpathys and Tagrisso combo
Chinese biopharma Hutchmed today announced that the Center for Drug Evaluation of China’s National Medical Products ...
Taiwan News11h
Asia Pacific Clinical Trials Market Structure Understanding Key Players and Their Influence
Taiwan says China sending largest naval fleet in years to region Request To Download Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Asia Pacific ...
Taiwan News11h
Asia Pacific Active Pharmaceutical Ingredients (API) Market Strategies How to Stay Competitive in 2025-2033
Request To Download Sample of This Strategic Report @ Taiwan says China sending largest naval fleet in years to region Highlighted with 88 tables and 75 figures, this 196-page report ?Asia Pacific ...
The American Journal of Managed Care16h
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data
Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...
24/7 Wall St21h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The Pharma Letter22h
Santhera secures first DMD approval in China
Santhera Pharmaceuticals gains approval in China for Agamree, the first Duchenne muscular dystrophy therapy available for ...